Skin autofluorescence provides additional information to the UK Prospective Diabetes Study (UKPDS) risk score for the estimation of cardiovascular prognosis in type 2 diabetes mellitus

被引：0
|
作者：
H. L. Lutgers
E. G. Gerrits
R. Graaff
T. P. Links
W. J. Sluiter
R. O. Gans
H. J. Bilo
A. J. Smit
机构：
[1] University Medical Center Groningen,Department of Internal Medicine
[2] Diabetes Center,Department of Biomedical Engineering
[3] Isala Clinics,Department of Endocrinology
[4] University Medical Center Groningen,Department of Medicine
[5] University Medical Center Groningen,undefined
[6] University of Groningen,undefined
来源：
Diabetologia | 2009年 / 52卷
关键词：
Advanced glycation end-products; Complications; Fluorescence; Type 2 diabetes; UKPDS risk score;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] Type 2 diabetes mellitus is not a cardiovascular risk equivalent
    Saely, CH
    Marte, T
    Aczel, S
    Langer, P
    Koch, L
    Schmid, F
    Drexel, H
    DIABETES, 2005, 54 : A182 - A183
  • [32] Cardiovascular risk in the spectrum of type 2 diabetes mellitus
    Ahmed, Intekhab
    Goldstein, Barry J.
    MOUNT SINAI JOURNAL OF MEDICINE, 2006, 73 (05): : 759 - 768
  • [33] Estimating Cardiovascular Risk in People with Type 2 Diabetes and Cardiovascular Disease: UKPDS Outcomes Model
    Coleman, Ruth L.
    Gray, Alastair M.
    Mcguire, Darren K.
    Holman, Rury R.
    DIABETES, 2019, 68
  • [34] Ethnicity and skin autofluorescence-based risk-engines for cardiovascular disease and diabetes mellitus
    Ahmad, Muhammad Saeed
    Kimhofer, Torben
    Ahmad, Sultan
    AlAma, Mohammed Nabil
    Mosli, Hala Hisham
    Hindawi, Salwa Ibrahim
    Mook-Kanamori, Dennis O.
    Sebekova, Katarina
    Damanhouri, Zoheir Abdullah
    Holmes, Elaine
    PLOS ONE, 2017, 12 (09):
  • [35] Exenatide improves cardiovascular risk factors in obese patients with type 2 diabetes mellitus: a prospective study
    Koseoglu, Derya
    Koparal, Salih Suha
    Baser, Ozden Ozdemir
    Berker, Dilek
    TURKISH JOURNAL OF MEDICAL SCIENCES, 2021, 51 (01) : 167 - 174
  • [36] Risk factors for renal dysfunction in type 2 diabetes - UK prospective diabetes study 74
    Retnakaran, Ravi
    Cull, Carole A.
    Thorne, Kerensa I.
    Adler, Amanda I.
    Holman, Rury R.
    DIABETES, 2006, 55 (06) : 1832 - 1839
  • [37] Skin Autofluorescence as a Potential Adjunctive Marker for Cardiovascular Risk Assessment in Type 2 Diabetes: A Systematic Review
    Reurean-Pintilei, Delia
    Pantea Stoian, Anca
    Potcovaru, Claudia-Gabriela
    Salmen, Teodor
    Cinteza, Delia
    Stoica, Roxana-Adriana
    Lazar, Sandra
    Timar, Bogdan
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (07)
  • [38] Estimating cardiovascular disease risk for individuals with Type 2 diabetes: the new UKPDS Risk Engine
    Coleman, R. L.
    Stevens, R. J.
    Holman, R. R.
    DIABETIC MEDICINE, 2007, 24 : 56 - 56
  • [39] Cardiovascular risk assessment in type 2 diabetes mellitus: comparison of the World Health Organization/International Society of Hypertension risk prediction charts versus UK Prospective Diabetes Study risk engine
    Herath, Herath M. Meththananda
    Weerarathna, Thilak Priyantha
    Umesha, Dilini
    VASCULAR HEALTH AND RISK MANAGEMENT, 2015, 11 : 583 - 589
  • [40] Development and progression of nephropathy in type 2 diabetes: The United Kingdom Prospective Diabetes Study (UKPDS 64)
    Adler, AI
    Stevens, RJ
    Manley, SE
    Bilous, RW
    Cull, CA
    Holman, RR
    KIDNEY INTERNATIONAL, 2003, 63 (01) : 225 - 232
12345